Skip to main content
. 2011 May;163(1):96–105. doi: 10.1111/j.1476-5381.2011.01222.x

Table 3.

Summery of published genome-wide association study in respiratory diseases and traits

Gene Phenotype Sample size and ethnicity Year Genome-wide significant findings (Yes/No) Comments Ref
ORMDL3 Childhood asthma Discovery:994 /1,243 * (Caucasians)Replication:2320 subjects from Germany (Caucasians)3301 subjects from the British 1958 Birth Cohort (Caucasians) 2007 Yes SNPs in the 17q21 region showed a strong association with childhood asthma in both a UK family cohort and German case-control samples. SNPs in this region were also associated with increased ORMDL3 mRNA expression in lymphoblastoid cell lines from asthmatic children. (Moffatt, Kabesch et al., 2007)
GSTO2 IL6R Quantitative pulmonary function measures 1097–1222 (depending on phenotype) individuals from the Framingham Heart Study population. (Caucasians) 2007 No The study utilized data on 71 000 SNPs. Two genes where proposed as potential candidate genes: GSTO2 and IL6R. (Wilk, Walter et al., 2007)
CHI3L1 Asthma, bronchial hyperresponsiveness and measures of pulmonary function 632 Hutterites(Caucasian) 2008 Yes Variants associated with elevated serum YKL-40 levels. YKL-40 was previously reported to be increased in the lungs and circulation of patients with severe asthma. (Ober, Tan et al., 2008)
PDE4D Asthma Discovery:359 /846 * (Caucasians)Replication:Ten independent populations with different ethnicities totalling 18 891 individuals (4342 cases) 2009 No Cases from the Childhood Asthma Management Program (CAMP) and genetically matched controls from the Illumina ICONdb public resource. The strongest region of association seen was on chromosome 5q12 in PDE4D (Himes, Hunninghake et al., 2009)
ADRA1B PRNP DPP10 Asthma Discovery:464 /471 * (African American)929 asthmatics and their family members (African Caribbean)Replication:994 / 1243* and 207 families (Caucasians)1456/1973*, 200/200*, 264 /186*, 208/179 * (African Americans) 2009 No None of the SNPs implicated in the discovery population were replicated in two European cohorts and four additional case-control studies of African Americans. (Mathias, Grant et al., 2010)
TLE4 CHCHD9 Childhood asthma Discovery:492 Trios (Mexicans)Replication:177 Trios (Mexicans) 2009 No Cases were children with asthma, predominantly atopic by skin prick test, and their parents using the Illumina HumanHap 550 K BeadChip. (Hancock, Romieu et al., 2009)
IL1RL1 IKZF2 GATA2 IL5 SH2B3 Plasma eosinophil count Discovery:9392 (Icelanders)Replication:12 118 (Europeans)5212 (East Asians) 2009 Yes Variants in IL1RL1, IKZF2, GATA2, IL5, and SH2B3 showed association with eosinophil count. Three SNPs in IL1RL1, IL33 and WDR36 have also showed association with atopic asthma, with the IL1RL1 SNP showing association with asthma as well. (Gudbjartsson, Bjornsdottir et al., 2009)
DENND1B CRB1 Asthma Discovery:793/1988* (Europeans)Replication:917/1546* (Europeans)1667/2045* (African Americans) 2010 Yes The study also implicated the 17q21 locus harbouring ORMDL3 (Sleiman, Flory et al., 2010)
RAD50 IL13 HLA-DQB1 Asthma 473/1892* (Caucasians) 2010 No Cases from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) and 1892 Illumina general population controls. (Li, Howard et al., 2010)
HHIP FEV1/FVC ratio Discovery:7691 (Caucasians)Replication:835 (Caucasians) 2009 Yes Individuals from the Framingham Heart Study. This time, by genotyping more SNPs (550 000 SNPs) in more individuals (7691), the study identified associations of SNPs on chromosome 4q31 near HHIP with the percent predicted FEV1/FVC ratio (Wilk, Chen et al., 2009)
CHRNA 3 CHRNA 5 HHIP COPD Discovery:823/810* (Caucasians)Replication:389/472* (Caucasians)2840 Caucasians family members 2009 Yes The first GWAS for COPD. The study investigated association with ∼500 000 SNPs. The HHIP locus did not reach genome-wide significance. (Pillai, Ge et al., 2009)
GSTCD TNS1 HHIP HTR4 AGER THSD4 Lung function measures(FEV1 and FEV1/FVC) Discovery:20 288 (Caucasians)Replication:32 184 direct genotyping (Caucasians)22 092 in silico replication (Caucasians)54 276 total 2010 Yes SpiroMeta consortium meta-analysis.>2.5 million genotyped and imputed SNPs tested.mRNA expression analysis showed all variants to be expressed in lung tissue. (Repapi, Sayers et al., 2010)
GSTCD HHIP HTR4 AGER GPR126 ADAM19 FAM13A PTCH1 PID1 Lung function measures(FEV1 and FEV1/FVC) Discovery:20 890 (Caucasians)Replication:16 178 in silico (Caucasians) 2010 Yes CHARGE consortium meta-analysis. (Hancock, Eijgelsheim et al., 2010)
FAM13A HHIP CHRNA3 CHRNA5 IREB2 COPD Discovery:2940 /1380* (Caucasians)Replication:502/504* and two family-basedcohorts (n = 3808) (Caucasians) 2010 Yes (Cho, Boutaoui et al., 2010)
HLA-DQ IL1RL1 IL18R1 IL33 SMAD3 IL2RB GSDMA GSDMB Asthma Discovery:10 365/16 110 * (Caucasians) 2010 Yes The GABRIEL (A Multidisciplinary Study to Identify the Genetic and Environmental Causes of Asthma in the European Community) Consortium.Association with the ORMDL3/GSDMB locus on chromosome 17q21 was specific to childhood-onset disease. Only HLA-DR showed a significant genome wide association with the total serum IgE concentration (Moffatt, Gut et al., 2010)
BICD1 Emphysema (Both qualitative and quantitative) Caucasian subjects from three cohorts (n = 1586, 435 and 362) 2010 Yes BICD1 gene were previously associated with telomere length in leukocytes (Kong, Cho et al., 2010)
*

Number of cases/number of controls.